These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2540516)

  • 21. Experimental studies on hepatic cirrhosis and hepatocarcinogenesis. II. Influence of cirrhotic liver on 2-FAA hepatocarcinogenesis in rats.
    Shimizu A
    Acta Pathol Jpn; 1986 Jul; 36(7):1039-48. PubMed ID: 3529810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Route-dependent, organ-specific effects of carcinogens on induction of hyperplastic liver nodules in rats.
    Hasegawa R; Tsuda H; Nakanishi K; Tatematsu M; Ito N
    Toxicol Lett; 1982 Dec; 14(3-4):229-35. PubMed ID: 7167983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of different initiation protocols in the resistant hepatocyte model.
    Espandiari P; Robertson LW; Srinivasan C; Glauert HP
    Toxicology; 2005 Jan; 206(3):373-81. PubMed ID: 15588927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide.
    Furuya K; Williams GM
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):63-9. PubMed ID: 6729822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic liver injury by thioacetamide and promotion of hepatic carcinogenesis.
    Gervasi PG; Longo V; Marzano M; Saviozzi M; Malvaldi G
    J Cancer Res Clin Oncol; 1989; 115(1):29-35. PubMed ID: 2921270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dietary selenium concentration on the development of enzyme-altered liver foci and hepatocellular carcinoma induced by diethylnitrosamine or N-acetylaminofluorene in rats.
    LeBoeuf RA; Laishes BA; Hoekstra WG
    Cancer Res; 1985 Nov; 45(11 Pt 1):5489-95. PubMed ID: 2865004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine.
    Williams GM; Iatropoulos MJ; Jeffrey AM
    Toxicol Pathol; 2000; 28(3):388-95. PubMed ID: 10862555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary culture of preneoplastic hepatocytes from rats treated with 2-acetylaminofluorene and clofibrate: relationship between resistance to dimethylnitrosamine and responsiveness of peroxisomes.
    Sawada N; Furukawa K; Gotoh M; Mochizuki Y; Tsukada H
    Gan; 1982 Feb; 73(1):1-6. PubMed ID: 7117736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumorigenicity of 3'-hydroxymethyl, 3'-formyl, and 3'-carboxy derivatives of 4-(dimethylamino)azobenzene in rat liver.
    Mori Y; Nagai H; Hori T; Niwa T; Toyoshi K; Koda A; Kawada K; Ojima A
    Gan; 1981 Feb; 72(1):160-5. PubMed ID: 6791985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect of radiation on N-2-fluorenylacetamide-induced hepatocarcinogenesis in male ACI/N rats.
    Mori H; Iwata H; Morishita Y; Mori Y; Ohno T; Tanaka T; Sasaki S
    Jpn J Cancer Res; 1990 Oct; 81(10):975-8. PubMed ID: 2121684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late target protein of the carcinogen N-2-fluorenylacetamide in rat liver.
    Munir KM; Blackburn GR; Sorof S
    Cancer Res; 1988 Dec; 48(23):6745-52. PubMed ID: 3180085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevation of collagenase activity in fatty liver.
    Watanabe A; Kobayashi M
    Hiroshima J Med Sci; 1987 Dec; 36(4):417-9. PubMed ID: 2834308
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.
    Smith LD; Emerson RL; Nixon LK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2132-8. PubMed ID: 445410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The air pollutant 2-nitrofluorene as initiator and promoter in a liver model for chemical carcinogenesis.
    Möller L; Torndal UB; Eriksson LC; Gustafsson JA
    Carcinogenesis; 1989 Mar; 10(3):435-40. PubMed ID: 2924391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of tumor specific antigens on the plasma membrane surface of rat hepatomas induced by 3'-Me DAB and identification of the common tumor specific antigens from rat hepatomas induced by different chemical hepatocarcinogens.
    Kim YS; Hahm KS; Kim KS; Lee NJ
    Yonsei Med J; 1988; 29(1):17-28. PubMed ID: 3381545
    [No Abstract]   [Full Text] [Related]  

  • 39. Dose and sex dependent effects of 2-acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene and DL-ethionine in induction of gamma-glutamyl transpeptidase-positive liver cell foci in rats.
    Tamano S; Tsuda H; Fukushima S; Masui T; Hosoda K; Ito N
    Cancer Lett; 1983 Oct; 20(3):313-21. PubMed ID: 6138146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
    Shirai T; Hosoda K; Hirose K; Hirose M; Ito N
    Cancer Lett; 1985 Sep; 28(2):127-33. PubMed ID: 2865001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.